In today’s world, easy access to advanced medicines is very important to treat cancer, rare disorders, and certain other life-threatening diseases. Unfortunately, so many critical medicines are not available in every country. Due to this reason, patients and healthcare providers (HCPs) search for reliable sources that can solve their problems. This is where the Indian Pharma Network (IPN) plays an important role. IPN provides easy access to high-quality, hard-to-obtain medicines sourced from top manufacturers across the world for patients in need.
Our Expertise in Hard-to-Find Medicines:
Indian Pharma Network (IPN) specializes in sourcing and supplying difficult-to-access medicines that are often unavailable or hard to procure in India, including:
- FDA-approved oncology medicines including Keytruda (Pembrolizumab), Opdivo (Nivolumab), Enhertu (Fam-Trastuzumab Deruxtecan-nxki), Lenvima (Lenvatinib), Cabometyx (Cabozantinib), Tecentriq (Atezolizumab), Imfinzi (Durvalumab), Ibrance (Palbociclib), Kisqali (Ribociclib), and Xtandi (Enzalutamide).
- Advanced biologics and immunotherapies including Humira (Adalimumab), Remicade (Infliximab), Avastin (Bevacizumab), Prolia (Denosumab), Actemra (Tocilizumab), Tysabri (Natalizumab), Cosentyx (Secukinumab), Dupixent (Dupilumab), Stelara (Ustekinumab), and Kineret (Anakinra).
- Rare disease treatments like enzyme replacement therapies including Zolgensma (Onasemnogene Abeparvovec), Spinraza (Nusinersen), Aldurazyme (Laronidase), Myozyme (Alglucosidase Alfa), Elaprase (Idursulfase), Vimizim (Elosulfase Alfa), Brineura (Cerliponase Alfa), Fabrazyme (Agalsidase Beta), Lumizyme (Alglucosidase Alfa), and Naglazyme (Galsulfase).
- Novel antivirals and antibiotics including Veklury (Remdesivir), Tamiflu (Oseltamivir), Paxlovid (Nirmatrelvir/Ritonavir), Baricitinib (Olumiant), Foscavir (Foscarnet), Zithromax (Azithromycin), Tygacil (Tigecycline), Daptomycin (Cubicin), Linezolid (Zyvox), and Meropenem (Merrem).
- Post-transplant immunosuppressants and anti-rejection medicines including Prograf (Tacrolimus), CellCept (Mycophenolate Mofetil), Neoral (Cyclosporine), Rapamune (Sirolimus), Zortress (Everolimus), Thymoglobulin (Anti-Thymocyte Globulin), Simulect (Basiliximab), Belatacept (Nulojix), Cytogam (CMV Immune Globulin), and Imuran (Azathioprine).
- Medicines used in Neurology and hematology including Ocrevus (Ocrelizumab), Spinraza (Nusinersen), Tysabri (Natalizumab), Soliris (Eculizumab), Ultomiris (Ravulizumab), Reblozyl (Luspatercept-aamt), Nplate (Romiplostim), Rituxan (Rituximab), Eltrombopag (Promacta), and Adcetris (Brentuximab Vedotin).
Hospitals-Institutions We Can Proudly Serve:
- Apollo Hospitals: As one of India’s largest healthcare providers (HCPs), Apollo Hospitals is known for offering world-class treatments. We can ensure a reliable and continuous supply of hard-to-find, newly approved import medicines for patients in Apollo Hospitals, including advanced therapies for cancer, rare diseases, and more.
- Adyar Cancer Institute (Chennai): This prestigious institution specializes in cancer care and research. We can provide access to FDA-approved oncology medicines and other targeted therapies required for advanced cancer treatment at Adyar Cancer Institute.
- MIOT International Hospital (Chennai): It is known for its multidisciplinary care. We can import life-saving medicines required for life-threatening conditions. We can ensure patients at MIOT receive the most genuine treatment options.
- Fortis Malar Hospital (Chennai): Fortis Malar is a trusted name in cardiac and cancer care. We can support Fortis Malar by supplying high-quality import medicines, that help enhance their ability to provide world-class treatments to their patients.
- Gleneagles Global Health City (Chennai): As a leader in multi-organ transplants and advanced care, Gleneagles Global Health City requires specialized medicines for complex procedures. IPN can provide uninterrupted access to these essential drugs and support their pioneering work in healthcare.
Cities We Operate In:
As a trusted pharmaceutical importer, we serve PAN India including multiple cities across South India:
- Chennai: Partnering with top hospitals for seamless delivery of import medicines.
- Bangalore: We can support leading healthcare providers (HCPs) with advanced therapies for rare diseases and life-threatening medical conditions.
- Hyderabad: We can help facilitate access to globally sourced medicines for critical care patients.
- Kerala: We can avail specialized import medicines for premier hospitals and institutions.
Why Choose Indian Pharma Network?
- Global Access to Medicines: IPN sources FDA-approved, EMA-authorized, PDMA-certified, and other globally approved medicines that may not be accessible in India.
- Trusted by Leading Hospitals: We collaborate with India`s top-tier hospitals so patients receive on-time access to the necessary treatments.
- Compliance and Quality Assurance: All hard-to-access medicines are sourced through legal and compliant channels that enhance our authenticity and quality of medicines.
- Seamless Logistics: With expertise in supply chain management, we provide timely delivery of medicines. IPN maintains the cold-chain requirements and follows international standards.
Making a Difference in Patient Care:
IPN believes every patient deserves easy access to the treatment they deserve, regardless of geographic or regulatory boundaries. Our work directly impacts lives by helping hospitals provide hard-to-source treatment for life-threatening and rare conditions. Whether it’s patients in Chennai diagnosed with cancer requiring a novel immunotherapy drug or children in Kerala needing enzyme replacement therapy, we can facilitate the supply of these medicines to those in need.
Contact Us:
Indian Pharma Network (IPN) is one of the most trusted partners for hospitals and institutions in India that legally delivers hard-to-find imported medicines. For inquiries or to place an order, please Call/WhatsApp: +91 9310090915 or write us at: info@indianpharmanetwork.com. Let’s work together to bring hard-to-access life-saving medicines to those who need them the most.
What kind of hard-to-find medicines does the Indian Pharma Network (IPN) supply?
We specialize in supplying critical medicines such as FDA-approved oncology drugs, advanced biologics, rare disease therapies, immunosuppressants, and novel antivirals. We source these medicines globally to ensure patients in India and other countries get access to the treatments they need.
Can you supply medicines like Trodelvy, Braftovi, and Blincyto to hospitals in India?
Yes, we can supply life-saving medicines including Trodelvy, Braftovi, Tukysa, Blincyto, Tibsovo, Padcev, Kineret, Retevmo, Soliris, Zavesca, and Zelboraf to leading hospitals such as Apollo Hospitals, MIOT International Hospital, Fortis Malar, Adyar Cancer Institute, and Gleneagles Global Health City across cities like Chennai, Bangalore, Hyderabad, and Kerala.
How do you ensure the quality and authenticity of medicines?
We source the best-quality genuine medicines through legal, globally compliant channels. All life-saving medicines are FDA-approved, EMA-authorized, or PDMA-certified, ensuring their authenticity, quality, and safety. Our operations follow WHO-GDP guidelines for pharmaceutical supply.
Which cities and hospitals do you serve in India?
We operate PAN India, including cities like Chennai, Bangalore, Hyderabad, Delhi, Lucknow, Gurgaon, Kolkata, and Kerala. We partner with top hospitals like Apollo Hospitals, Adyar Cancer Institute, MIOT International, Fortis Malar, and Gleneagles Global Health City to deliver essential medicines.
Why should hospitals trust Indian Pharma Network for importing hard-to-access medicines?
Hospitals trust us for our:
- Global access to FDA and EMA-approved medicines.
- Compliance with quality assurance standards.
- Seamless cold-chain logistics ensuring medicines are delivered safely and on time.
- Commitment to making life-saving treatments available to patients in need.
For further assistance, hospitals and institutions can Call/WhatsApp: +91 9310090915 or email us at info@indianpharmanetwork.com.
